Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 09:40:48 GMT 2023
by
admin
on
Sat Dec 16 09:40:48 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
EFE6X5M3UY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
113498
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
||
|
FDA ORPHAN DRUG |
117998
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
||
|
NCI_THESAURUS |
C2456
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2108501
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
DB05097
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
KK-115
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
C2043
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
8127
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
219649-07-7
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
Labetuzumab
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY | |||
|
EFE6X5M3UY
Created by
admin on Sat Dec 16 09:40:48 GMT 2023 , Edited by admin on Sat Dec 16 09:40:48 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_146 | 1_202 |
| 1_222 | 3_213 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| 1_263 | 1_323 |
| 1_369 | 1_427 |
| 2_22 | 2_96 |
| 2_146 | 2_202 |
| 2_222 | 4_213 |
| 2_263 | 2_323 |
| 2_369 | 2_427 |
| 3_23 | 3_88 |
| 3_133 | 3_193 |
| 4_23 | 4_88 |
| 4_133 | 4_193 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> DERIVATIVE | |||
|
|
PARENT -> DERIVATIVE | |||
|
PARENT -> CONJUGATE | |||
|
|
PARENT -> DERIVATIVE | |||
|
TARGET->LIGAND | |||
|
INGREDIENT -> STARTING MATERIAL |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|